The Next Frontier in MIS
Magnetic Surgery

GT Metabolic is leading the world with its development of magnetic compression anastomosis technologies. 1

Bariatric, Metabolic, and
Digestive Surgery —
Reinvented

An elegant approach that uses magnets to help achieve anastomosis, the incisionless technique leaves behind no foreign material to impede the natural tissue healing process.

Connecting the World to
Safer Surgical Solutions

GT Metabolic is partnering with leading bariatric and metabolic surgeons all over the world to deliver minimally invasive products and techniques that are better for surgeons and patients.

The Latest from GT Metabolic –
Revolutionary Magnetic Compression Surgical Technique to Launch in U.S. Market

The MagDI™ System is poised to launch a new frontier in healthcare as we continue to deliver on our visionary milestones for efficacy in magnetic surgery.

The GT MetabolicTM Difference

GT Metabolic is leading the world with its development of magnetic compression anastomosis technologies for next-stage minimally invasive procedures.1 An elegant approach that uses magnets to help achieve anastomosis, the incisionless, sutureless, staple-free technique leaves behind no foreign material to impede the natural tissue healing process. 1-4

In clinical studies supporting De Novo marketing authorization of our first-generation Magnet, a novel, less-invasive technique enabled us to change how we approach duodeno-ileostomy anastomosis during bariatric surgery. Magnets were used to create a duodeno-ileal (DI) anastomosis. The anastomosis creates partial diversion of intestinal contents; this is intended to facilitate durable weight loss and improve glycemic control in obese patients with or without type 2 diabetes. A side-to-side DI anastomosis can now be performed magnetically, with no bowel incisions. Second-generation Magnet already in clinical studies.1-4

  1. De Novo marketing authorization DEN240013. MagDI™ System for side-to-side duodeno-ileal anastomosis granted De Novo marketing authorization from the U.S. Food and Drug Administration (FDA). 2 July 2024.
  2. Gagner, M., Almutlaq, L., Cadiere, G.-B., Torres, A. J., Sanchez-Pernaute, A., Buchwald, J. N., & Abuladze, D. (2023). Side-to-side magnetic duodeno-ileostomy in adults with severe obesity with or without type 2 diabetes: Early outcomes with prior or concurrent sleeve gastrectomy. Surgery for Obesity and Related Diseases. https://doi.org/10.1016/j.soard.2023.10.018.
  3. Gagner, M., Abuladze, D., Koiava, L. et al. First-in-Human Side-to-Side Magnetic Compression Duodeno-ileostomy with the Magnet Anastomosis System. OBES SURG 33, 2282–2292 (2023). https://doi.org/10.1007/s11695-023-06708-x.
  4. Gagner M, Cadiere GB, Sanchez-Pernaute A, Abuladze D, Krinke T, Buchwald JN, Van Sante N, Van Gossum M, Dziakova J, Koiava L, Odovic M, Poras M, Almutlaq L, Torres AJ. Side-to-side magnet anastomosis system duodeno-ileostomy with sleeve gastrectomy: early multi-center results. Surg Endosc. 2023 Aug;37(8):6452-6463. doi: 10.1007/s00464-023-10134-6. Epub 2023 May 22. PMID: 37217682; PMCID: PMC10202352.